Literature DB >> 24327810

Induction of a Soluble Anti-HIV-1 factor (s) with IFN-γ, IL-10, and β-Chemokine Modulating Activity by an Influenza-Bacterial Polyantigenic Mixture.

José W Rodríguez1, Nat O Pagan, María C Ocasio, Zilka Ríos, Luis A Cubano, Nawal M Boukli, Miguel Otero, Robert Hunter, Madhavan P Nair, Eddy Rios-Olivares.   

Abstract

Partial immune restoration may be obtained with highly active antiretroviral therapy (HAART), but specific anti-HIV-1 immune responses do not appear to improve substantially. We have demonstrated that a soluble factor(s) induced by a mixture of inactivated influenza and bacterial vaccines called polyantigenic immunomodulator (PAI), possesses strong immunoregulatory and anti-HIV-1 activities. In the present study, we show that culture fluids from both PAI-stimulated peripheral blood mononuclear cells (PBMC) and CD8+ T-cells of HIV-1 infected patients were able to suppress HIV-1 replication in an MHC-unrestricted fashion. The PAI-induced antiviral activity was eliminated when culture fluids were pre-heated at 100°C for 10 min. and it is associated with induction of IFN-γ, MIP-1α, MIP-1β, and RANTES production, but inhibition of IL-10. Furthermore, this induction is dependent on the immunological status (CD4:CD8 ratio) of the HIV-1 infected patient. Taken together, our results suggest that the MHC-unrestricted HIV-1 suppression that is induced by culture fluids from PAI-stimulated PBMC may result from the stimulation of immune cell subpopulations to produce a heat-labile antiviral soluble factor(s), which in turn modulate cytokine and β-chemokine production. The identification of this PAI-induced soluble factor(s) may have major therapeutic potential.

Entities:  

Keywords:  Human Immunodeficiency virus-1 (HIV-1); antiviral activity; cytokines; polyantigenic immunomodulator (PAI); β-chemokines

Year:  2007        PMID: 24327810      PMCID: PMC3856246          DOI: 10.3844/ajidsp.2007.267.275

Source DB:  PubMed          Journal:  Am J Infect Dis        ISSN: 1553-6203


  48 in total

1.  IL-13 acts on macrophages to block the completion of reverse transcription, inhibit virus production, and reduce virus infectivity.

Authors:  L J Montaner; R T Bailer; S Gordon
Journal:  J Leukoc Biol       Date:  1997-07       Impact factor: 4.962

Review 2.  Control of HIV-1 infection by soluble factors of the immune response.

Authors:  Anthony L DeVico; Robert C Gallo
Journal:  Nat Rev Microbiol       Date:  2004-05       Impact factor: 60.633

Review 3.  Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.

Authors:  Fernando Aiuti; Ivano Mezzaroma
Journal:  AIDS Rev       Date:  2006 Apr-Jun       Impact factor: 2.500

Review 4.  Chemokines and defensins as HIV suppressive factors: an evolving story.

Authors:  Alfredo Garzino-Demo
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

5.  Immune restoration under HAART in patients chronically infected with HIV-1: diversity of T, B, and NK immune responses.

Authors:  H Le Guillou-Guillemette; G Renier; B Vielle; P Abgueguen; J-M Chennebault; F Lunel; C Payan
Journal:  Viral Immunol       Date:  2006       Impact factor: 2.257

6.  Survival and quality of life in HIV-positive patients treated with a polyantigenic immunomodulator.

Authors:  J I Colón; G Encarnación; M R Ortiz Santini; M T Rodríguez Malavé; E A Santiago Delpín; A M Marchand
Journal:  P R Health Sci J       Date:  1997-03       Impact factor: 0.705

Review 7.  Chemokines and chemokine receptors in HIV infection: role in pathogenesis and therapeutics.

Authors:  P Suresh; A Wanchu
Journal:  J Postgrad Med       Date:  2006 Jul-Sep       Impact factor: 1.476

8.  Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism.

Authors:  C M Walker; A L Erickson; F C Hsueh; J A Levy
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women.

Authors:  B K Patterson; H Behbahani; W J Kabat; Y Sullivan; M R O'Gorman; A Landay; Z Flener; N Khan; R Yogev; J Andersson
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

10.  Purification of a modified form of bovine antithrombin III as an HIV-1 CD8+ T-cell antiviral factor.

Authors:  Ralf Geiben-Lynn; Nancy Brown; Bruce D Walker; Andrew D Luster
Journal:  J Biol Chem       Date:  2002-08-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.